Interaction of caffeine with the GABAA receptor complex: alterations in receptor function but not ligand binding.

European Journal of Pharmacology
F LopezR I Shader

Abstract

Behavioral and neurochemical evidence indicates interactions between caffeine and other adenosine receptor ligands and the gamma-aminobutyric acid (GABA)-benzodiazepine system. To assess the effects of caffeine on binding and function at the GABAA receptor, we studied the effects of behaviorally-active doses of caffeine on benzodiazepine and Cl- channel binding and on overall function of the GABAA receptor as measured by Cl- uptake. There was no effect of caffeine on benzodiazepine receptor binding in cortical synaptosomal membranes at concentrations of 1-100 microM. No effects on benzodiazepine binding were found ex vivo in mice treated with caffeine, 20 and 40 mg/kg. At the putative Cl- channel site labeled by t-butylbicyclophosphorothionate (TBPS), binding was unchanged in vitro after caffeine treatment (1 and 10 microM) in washed and unwashed membranes. However, in ex vivo studies caffeine (20 and 40 mg/kg) increased numbers of TBPS sites in unwashed but not washed membranes. Muscimol-stimulated Cl- uptake into cortical synaptoneurosomes was decreased in mice treated with caffeine, 20 and 40 mg/kg. Similar results were observed in in vitro preparations treated with 50 microM but not 100 microM caffeine. These results indica...Continue Reading

References

Apr 21, 1977·Nature·R F Squires, C Brastrup
Mar 18, 1986·European Journal of Pharmacology·A Y ChwehE A Swinyard
Jan 1, 1988·Progress in Neuro-psychopharmacology & Biological Psychiatry·J W Phillis, M H O'Regan
Mar 1, 1987·Biopharmaceutics & Drug Disposition·L G MillerR I Shader
Apr 14, 1987·European Journal of Pharmacology·J W Phillis, R E Stair
Apr 1, 1987·Pharmacology, Biochemistry, and Behavior·J D Roache, R R Griffiths
Aug 1, 1981·Canadian Journal of Physiology and Pharmacology·M WilliamsJ R Huff
Aug 18, 1983·The New England Journal of Medicine·D J GreenblattD R Abernethy
Dec 1, 1983·Neuropharmacology·R F BrunsJ W Daly
May 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·S H SnyderJ W Daly
Aug 1, 1983·Computer Programs in Biomedicine·G A McPherson
Jan 27, 1984·European Journal of Pharmacology·S V Vellucci, R A Webster
Jan 1, 1981·Psychopharmacology·P J MarangosP Skolnick
May 18, 1981·Life Sciences·P PolcW E Haefely

❮ Previous
Next ❯

Citations

Aug 1, 1990·Brain Research Bulletin·A SchatzkiL G Miller
Jun 28, 2000·Journal of the Autonomic Nervous System·J W Daly
Apr 15, 2014·Brain Research Bulletin·Jana D TchekalarovaPavel Mareš
May 1, 1998·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·J H MedinaA C Paladini
Apr 19, 2007·Brain Research·Jana TchekalarovaPavel Mares
Jan 21, 2010·Molecular Nutrition & Food Research·Silvia RossiDiego Centonze
Mar 15, 2013·Neurochemistry International·Mauren Assis SouzaLuiz Fernando Freire Royes
Jun 6, 2009·Seizure : the Journal of the British Epilepsy Association·Jana TchekalarovaPavel Mares
Jul 30, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·João P MonteiroBranca M Silva
Oct 26, 2016·Journal of Neurochemistry·Diogo M RomboAna M Sebastião
Apr 7, 2018·Critical Reviews in Food Science and Nutrition·João MonteiroBranca M Silva
Jul 9, 2020·International Journal of Molecular Sciences·Giovanni SchepiciEmanuela Mazzon
Jul 1, 2017·Journal of Caffeine Research·Rachel L Poole, Michael G Tordoff
Jan 23, 2018·Frontiers in Pharmacology·Amber KerkhofsHuibert D Mansvelder

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.